Rockwell Medical regains Nasdaq minimum bid price compliance; listing matter closed

ROCKWELL MEDICAL, INC.

Received Nasdaq notice on July 16, 2026 that bid price compliance is regained under Rule 5550(a)(2).
Stock maintained closing bid price of $1.00 or greater from July 1 to July 15, 2026.
Nasdaq has closed the compliance matter; company now in full compliance with all continued listing requirements.
Stock remains listed on Nasdaq Capital Market under ticker RMTI.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.